Academic Commercialization Pipeline MCP Server

> View on ApifyForge | Use on Apify Store

---

Quick Start

Add to your MCP client (Claude Desktop, Cursor, Windsurf):

{
  "mcpServers": {
    "academic-commercialization-pipeline-mcp": {
      "url": "https://ryanclinton--academic-commercialization-pipeline-mcp.apify.actor/mcp"
    }
  }
}

---

Academic commercialization intelligence for AI agents via the Model Context Protocol. This MCP server orchestrates 8 academic and patent data sources — OpenAlex, Semantic Scholar, ArXiv, USPTO, EPO, NIH Grants, Grants.gov, and ClinicalTrials.gov — to deliver a Commercialization Probability Score (0-100) composed from four independent scoring models: Research Momentum, Patent IP Strength, Funding Validation, and Technology Readiness Level (TRL) assessment.

Technology scouts, corporate venture teams, and tech transfer offices use this server to find spinout-ready research before competitors do. Rather than manually checking five databases, your AI agent calls a single tool and receives structured, scored intelligence within 90 seconds.

What data can you access?

| Data Point | Source | Example |
|-----------|--------|---------|
| 📄 Publications and citation counts | OpenAlex (250M+ works) | 847 citations, avg 34/paper |
| 🔬 AI-ranked academic search results | Semantic Scholar (200M+ papers) | 12 influential citations |
| 🇺🇸 US patent filings and granted patents | USPTO Patent Search | 6 granted, 3 applications |
| 🌍 European patent filings | EPO (100M+ patents) | 4 EPO filings, B-type grants |
| 💰 NIH grant awards and SBIR/STTR funding | NIH Grants | R01, SBIR Phase II |
| 🏛️ Federal grant opportunities and awards | Grants.gov | $2.4M awarded |
| 🧪 Clinical trial phases and sponsors | ClinicalTrials.gov | Phase 2, 340 enrolled |
| 📝 Pre-publication STEM preprints | ArXiv (2.4M+ preprints) | 8 preprints in 90 days |
| 🎯 Research Momentum Score | OpenAlex + Scholar + ArXiv | 74/100 — HIGH_MOMENTUM |
| 💡 Patent Commercialization Signal | USPTO + EPO + OpenAlex | 68/100 — STRONG_IP |
| 📊 Funding Validation Index | NIH + Grants.gov + Trials | 82/100 — TRANSLATION_STAGE |
| 🚀 TRL Assessment (1-9) | Patents + Trials + NIH | TRL 7 — PILOT |
| 🏆 Composite Commercialization Score | All 8 sources | 77/100 — INVEST_NOW |

Why use Academic Commercialization Pipeline MCP Server?

Manual technology scouting means opening five government databases, exporting CSVs, cross-referencing researcher names across patent and publication records, tracking grant histories, and then synthesizing findings into a coherent TRL assessment. A skilled analyst takes two to three days per technology area. Miss a patent filing or a Phase 2 trial announcement and the window for early-stage licensing closes.

This MCP server automates the entire pipeline. Your AI agent calls emerging_technology_radar once and receives a composite score derived from 8 live data sources in under two minutes. The scoring algorithms handle citation velocity calculation, author-to-inventor cross-referencing, SBIR grant trajectory analysis, and TRL keyword classification — returning a decision-ready verdict with supporting evidence signals.

Key platform benefits:

- Scheduling — run weekly technology radar scans via Apify Schedules to track how commercialization probability changes over time
- API access — trigger calls from Python, LangChain, CrewAI, or any HTTP client
- Proxy rotation — parallel actor calls handled by Apify's infrastructure without IP blocks
- Monitoring — get Slack or email alerts when runs fail via Apify webhooks
- Integrations — push scored results to Zapier, Make, Notion, or your CRM

Features

- 8 parallel data sources — OpenAlex, Semantic Scholar, ArXiv, USPTO, EPO, NIH Grants, Grants.gov, and ClinicalTrials.gov queried concurrently with a 120-second actor timeout per source
- 4 independent scoring models — Research Momentum (0-100), Patent Commercialization Signal (0-100), Funding Validation Index (0-100), and TRL Assessment (0-100) computed separately before compositing
- Weighted composite score — TRL carries 30% weight, Patent IP and Funding each 25%, Research Momentum 20%, reflecting empirical importance of late-stage signals
- 5-tier investment verdicts — INVEST_NOW, STRONG_CANDIDATE, MONITOR, TOO_EARLY, PASS — with an override rule: TRL 7+ combined with COMMERCIAL_READY IP status always escalates to INVEST_NOW
- Author-to-inventor cross-referencing — matches researcher surnames between OpenAlex authorships and USPTO/EPO inventor fields to detect publication-to-patent conversion
- Citation velocity calculation — computes average citations per paper and flags recency (post-2023 citations as a share of total) as a leading momentum indicator
- Momentum level classification — 5 tiers: DORMANT, EMERGING, ACCELERATING, HIGH_MOMENTUM, BREAKTHROUGH
- IP portfolio classification — 5 tiers: NO_IP, EARLY_FILING, PORTFOLIO_BUILDING, STRONG_IP, COMMERCIAL_READY
- Funding level classification — 5 tiers: UNFUNDED, SEED_STAGE, VALIDATED, WELL_FUNDED, TRANSLATION_STAGE
- TRL estimation from text — keyword analysis across patent abstracts and ArXiv papers classifies 9 high-TRL terms (commerc, manufactur, scale-up, fda approv), 6 mid-TRL terms (prototype, validat, feasib), and 3 low-TRL terms
- SBIR/STTR detection — identifies R43, R44, and STTR Phase II codes as high-weight commercialization signals, adding 5 points each to the NIH scoring component
- Clinical trial phase as TRL proxy — Phase 2 trials map to TRL 5-6, Phase 3 to TRL 7+, with phase number as a hard TRL floor override
- Evidence signals array — each scoring model returns plain-English signals (e.g., "6 granted patents — established IP portfolio") for agent reasoning chains
- Actionable recommendations — composite report includes specific next-step recommendations based on score profile gaps (e.g., "Strong TRL but weak IP — consider patent filing strategy")
- MCP Standby mode — server stays alive between requests, eliminating cold-start overhead for repeated queries
- Pay-per-event billing — charged only on successful tool calls; spending limits enforced per call to prevent runaway costs

Use cases for academic commercialization intelligence

Corporate venture technology sourcing

Corporate VC and M&A teams use this server to identify spinout-ready research before it becomes a known deal. The researcher_commercialization_signals tool detects when academic researchers begin converting publications into patents — typically 12-18 months before a formal spinout is announced. Running this scan across a target technology area weekly surfaces opportunities at the formation stage rather than after term sheets are circulating.

Tech transfer office pipeline management

Technology transfer officers use institution_innovation_profile to benchmark their commercialization pipeline against peer institutions. The tool pulls publication output, patent portfolio, and grant funding simultaneously and returns a structured profile showing which departments are generating strong IP signals versus which remain in basic research. Identify bottlenecks between publication and patent filing in a single query.

R&D build-vs-buy-vs-license strategy

Product strategy teams use emerging_technology_radar to assess whether a technology area is mature enough to license, early enough to develop internally, or at the right stage for an academic partnership. The TRL assessment (1-9) and funding trajectory tell you whether a technology has been validated by government funding or remains pre-commercial — the key distinction for licensing valuation.

Pharmaceutical partnership targeting

Pharma business development teams use clinical_translation_pipeline to track academic therapies moving through trial phases before Phase 2 results trigger competitive bidding. The tool cross-references ClinicalTrials.gov phases with NIH grant awards to identify which academic programs have both clinical traction and funding validation — the signature of acquisition-ready assets.

Patent landscape intelligence

IP strategy teams use patent_publication_crossref to map the IP landscape for a technology area before filing. The author-to-inventor cross-reference reveals which researchers are filing patents and with which assignees, giving insight into university licensing office strategies and potential freedom-to-operate issues. EPO coverage data indicates international filing intent.

Investor due diligence on deep tech

Deep tech investors use citation_velocity_analysis to validate whether a startup's technology claims are backed by genuine research momentum. A startup claiming breakthrough gene therapy innovation should have accelerating citations, recent preprints, and significant NIH grant backing. This tool surfaces that evidence in under a minute — before committing to a full diligence process.

How to use the Academic Commercialization Pipeline MCP Server

1. Connect the MCP server — Add the server URL to your MCP client configuration. For Claude Desktop, add https://academic-commercialization-pipeline-mcp.apify.actor/mcp under mcpServers. For other clients (Cursor, Windsurf, Cline), follow the same pattern.

2. Authenticate — Include your Apify API token as a Bearer token in request headers. You can find your token at console.apify.com/account/integrations.

3. Choose your tool — For a complete commercialization assessment, use emerging_technology_radar. For targeted analysis, use the focused tools: technology_breakthrough_scan for research signals, funding_flow_tracker for grant intelligence, or clinical_translation_pipeline for biomedical assets.

4. Receive structured results — Each tool returns a JSON response with scores, classification tiers, evidence signals, and supporting records (papers, patents, grants). Use the verdict field (INVEST_NOW, STRONG_CANDIDATE, MONITOR, etc.) to triage your pipeline.

MCP tools

| Tool | Price | Data sources | Returns |
|------|-------|-------------|---------|
| technology_breakthrough_scan | $0.045 | OpenAlex, Semantic Scholar, ArXiv | Research Momentum Score, momentum level, top papers, preprints |
| researcher_commercialization_signals | $0.045 | OpenAlex, USPTO, NIH | Patent Commercialization Signal, publications, patents, grants |
| citation_velocity_analysis | $0.045 | OpenAlex, Semantic Scholar | Citation velocity, momentum level, score, papers |
| patent_publication_crossref | $0.045 | USPTO, EPO, OpenAlex | Patent Commercialization Signal, cross-ref hits, USPTO and EPO records |
| funding_flow_tracker | $0.045 | NIH Grants, Grants.gov, ClinicalTrials.gov | Funding Validation Index, funding level, grants, trials |
| clinical_translation_pipeline | $0.045 | ClinicalTrials.gov, NIH, ArXiv | TRL estimate (1-9), TRL level, funding level, clinical trials |
| institution_innovation_profile | $0.045 | OpenAlex, USPTO, NIH, Grants.gov | Momentum level, IP strength, funding level, combined signals |
| emerging_technology_radar | $0.045 | All 8 sources | Full Commercialization Report with composite score and verdict |

Tool parameters

| Tool | Parameter | Required | Description |
|------|-----------|----------|-------------|
| technology_breakthrough_scan | technology | Yes | Technology or research area to scan (e.g., "mRNA therapeutics") |
| technology_breakthrough_scan | timeframe | No | Timeframe hint (e.g., "2023-2024") |
| researcher_commercialization_signals | researcher | Yes | Researcher name or institution (e.g., "Jennifer Doudna CRISPR") |
| researcher_commercialization_signals | field | No | Research field to narrow results |
| citation_velocity_analysis | query | Yes | Research topic, paper title, or author name |
| patent_publication_crossref | technology | Yes | Technology area or inventor name |
| funding_flow_tracker | technology | Yes | Technology or institution name to track funding for |
| clinical_translation_pipeline | therapy | Yes | Therapy, drug, or medical technology (e.g., "CAR-T cell therapy") |
| institution_innovation_profile | institution | Yes | University or research institution name |
| emerging_technology_radar | technology | Yes | Technology or research area for comprehensive analysis |
| emerging_technology_radar | sector | No | Industry sector context to narrow results (e.g., "oncology") |

Connection examples

Claude Desktop (claude_desktop_config.json):

{

  "mcpServers": {

    "academic-commercialization-pipeline": {

      "url": "https://academic-commercialization-pipeline-mcp.apify.actor/mcp",

      "headers": {

        "Authorization": "Bearer YOUR_APIFY_TOKEN"

      }

    }

  }

}

Cursor / Windsurf / Cline (mcp.json):

{

  "mcpServers": {

    "academic-commercialization-pipeline": {

      "url": "https://academic-commercialization-pipeline-mcp.apify.actor/mcp",

      "headers": {

        "Authorization": "Bearer YOUR_APIFY_TOKEN"

      }

    }

  }

}

Direct HTTP (cURL):

curl -X POST "https://academic-commercialization-pipeline-mcp.apify.actor/mcp" \

  -H "Content-Type: application/json" \

  -H "Authorization: Bearer YOUR_APIFY_TOKEN" \

  -d '{

    "jsonrpc": "2.0",

    "method": "tools/call",

    "params": {

      "name": "emerging_technology_radar",

      "arguments": {

        "technology": "solid-state batteries",

        "sector": "energy storage"

      }

    },

    "id": 1

  }'

Usage from code

Python (with LangChain MCP adapter):
```python
from langchain_mcp_adapters.client import MultiServerMCPClient

client = MultiServerMCPClient({
"academic-commercialization": {
"url": "https://academic-commercialization-pipeline-mcp.apify.actor/mcp",
"transport": "streamable_http",
"headers": {"Authorization": "Bearer YOUR_APIFY_TOKEN"},
}
})

tools = await client.get_tools()